PERSPECTA

News from every angle

Back to headlines

Taysha outlines 2026 BLA submission path for TSHA-102 as pivotal trial enrollment advances

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.